These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1642226)

  • 1. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
    Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
    Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
    Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface located procollagen N-propeptides on dermatosparactic collagen fibrils are not cleaved by procollagen N-proteinase and do not inhibit binding of decorin to the fibril surface.
    Watson RB; Holmes DF; Graham HK; Nusgens BV; Kadler KE
    J Mol Biol; 1998 Apr; 278(1):195-204. PubMed ID: 9571043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
    Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
    J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of types I and III procollagen in Ehlers-Danlos syndrome type VII.
    Halila R; Steinmann B; Peltonen L
    Am J Hum Genet; 1986 Aug; 39(2):222-31. PubMed ID: 3019133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
    Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
    J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis.
    Nusgens BV; Verellen-Dumoulin C; Hermanns-Lê T; De Paepe A; Nuytinck L; Piérard GE; Lapière CM
    Nat Genet; 1992 Jun; 1(3):214-7. PubMed ID: 1303238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide.
    Holmes DF; Watson RB; Steinmann B; Kadler KE
    J Biol Chem; 1993 Jul; 268(21):15758-65. PubMed ID: 8340401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
    Eyre DR; Shapiro FD; Aldridge JF
    J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
    Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK
    Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
    Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
    Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase.
    Wang WM; Lee S; Steiglitz BM; Scott IC; Lebares CC; Allen ML; Brenner MC; Takahara K; Greenspan DS
    J Biol Chem; 2003 May; 278(21):19549-57. PubMed ID: 12646579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene.
    Colige A; Sieron AL; Li SW; Schwarze U; Petty E; Wertelecki W; Wilcox W; Krakow D; Cohn DH; Reardon W; Byers PH; Lapière CM; Prockop DJ; Nusgens BV
    Am J Hum Genet; 1999 Aug; 65(2):308-17. PubMed ID: 10417273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis.
    Le Goff C; Somerville RP; Kesteloot F; Powell K; Birk DE; Colige AC; Apte SS
    Development; 2006 Apr; 133(8):1587-96. PubMed ID: 16556917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
    Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
    J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial observations of human dermatosparaxis: Ehlers-Danlos syndrome type VIIC.
    Wertelecki W; Smith LT; Byers P
    J Pediatr; 1992 Oct; 121(4):558-64. PubMed ID: 1403389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII.
    Cole WG; Chan D; Chambers GW; Walker ID; Bateman JF
    J Biol Chem; 1986 Apr; 261(12):5496-503. PubMed ID: 3082886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.